Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: INDICATIONS AND USAGE CLEOCIN PHOSPHATE products are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. US FDA label
Use: INDICATIONS AND USAGE Clotrimazole cream USP is indicated for the topical treatment of candidiasis due to Candida albicans and tinea versicolor due to Malassezia furfur. US FDA label
Use: Intra-Abdominal Infections, including peritonitis, intra-abdominal abscess and liver abscess, caused by Bacteroides species including the B. fragilis group ( B. fragilis , B. distasonis , B. ovatus , B. thetaiotaomicron… US FDA label
Kidney dosing: Metronidazole (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
- CrCl 30–59 mL/min
- No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
- CrCl 15–29 mL/min
- No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
- CrCl <15 mL/min (not on dialysis)
- No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label). In end-stage kidney disease, peak levels of hydroxy-metronidazole were 2 times and of metronidazole acetate 5 times normal (label PK). Because metabolites accumulate in end-stage kidney disease, monitoring for metronidazole-associated adverse events is recommended (label).
- Hemodialysis (intermittent)
- Hemodialysis (4 to 8 hours) removes 40% to 65% of a dose. If dosing cannot be separated from the session, consider a supplemental dose after hemodialysis (label).
- Peritoneal dialysis
- No dose change on CAPD; a 7.5-hour peritoneal dialysis removed about 10% of a dose (label).
- CRRT
- Not in label; the cited CRRT review (Li 2020) gives no regimen for this drug. Specialist input.
- Dialyzable? Hemodialysis: yes (40% to 65% of a dose per 4- to 8-hour session, by membrane and duration). Peritoneal dialysis: little (about 10%) (label). Under 20% protein bound.
- Monitoring Neurologic symptoms (encephalopathy, cerebellar signs, seizures, peripheral or optic neuropathy, aseptic meningitis); liver function in hepatic impairment; INR with warfarin; lithium and creatinine with lithium (label).
From the Metronidazole monograph (renalcarematters.com, reviewed).
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Softgel capsule for vaginal use: 100 mg/100 mg/100 mg
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Clindamycin + Clotrimazole + Metronidazole as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Vagclr-MClindamycin (as phosphate) + Clotrimazole + Metronidazole | 100 mg/100 mg/100 mg Softgel Capsule for Vaginal UseAlu/Clear PVC Blister Pack x 7's (Box of 7's); Alu/Clear PVC Blister Pack x 3's (Box of 3's); Alu/Clear PVC Blister Pack x 1's (Box of 1's) | Rx | Gelnova Laboratories (India) Pvt. Ltd.India | Danzz Pharma Marketing Inc.Importer: SRS Life Sciences Inc | DR-XY44451 | Jun 26, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .